US Patent Issued to ANTEROGEN on Oct. 27 for "Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,387, issued on Oct. 27, was assigned to ANTEROGEN Co. LTD (Seoul, South Korea).

"Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same" was invented by Sung-Koo Lee (Seoul, South Korea) and Mi-Hyung Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition containing injectable mesenchymal stem cell-hydrogel and a method of preparing the same. Specifically, in a mesenchymal stem cell-hydrogel composition for injection prepared by a method of the present invention, since stem cells are attached to scaffolds in hydro...